Expression of the calcium channel Ca V 2.2 is markedly suppressed by coexpression with truncated constructs of Ca V 2.2. Furthermore, a two-domain construct of Ca V 2.1 mimicking an episodic ataxia-2 mutation strongly inhibited Ca V 2.1 currents. We have now determined the specificity of this effect, identified a potential mechanism, and have shown that such constructs also inhibit endogenous calcium currents when transfected into neuronal cell lines. Suppression of calcium channel expression requires interaction between truncated and full-length channels, because there is inter-subfamily specificity. Although there is marked cross-suppression within the Ca V 2 calcium channel family, there is no cross-suppression between Ca V 2 and Ca V 3 channels. The mechanism involves activation of a component of the unfolded protein response, the endoplasmic reticulum resident RNA-dependent kinase (PERK), because it is inhibited by expression of dominant-negative constructs of this kinase. Activation of PERK has been shown previously to cause translational arrest, which has the potential to result in a generalized effect on protein synthesis. In agreement with this, coexpression of the truncated domain I of Ca V 2.2, together with full-length Ca V 2.2, reduced the level not only of Ca V 2.2 protein but also the coexpressed ␣2␦-2. Thapsigargin, which globally activates the unfolded protein response, very markedly suppressed Ca V 2.2 currents and also reduced the expression level of both Ca V 2.2 and ␣2␦-2 protein. We propose that voltage-gated calcium channels represent a class of difficult-to-fold transmembrane proteins, in this case misfolding is induced by interaction with a truncated cognate Ca V channel. This may represent a mechanism of pathology in episodic ataxia-2.
Introduction
Voltage-gated calcium channels serve a number of vital functions, including neurotransmitter release and muscle contraction (for review, see Catterall, 2000) . They are heteromeric complexes consisting of the pore-forming Ca V ␣1 subunit together (except in the case of the Ca V 3 channels) with an accessory ␤ and ␣2-␦ subunit. The Ca V ␣1 subunit consists of four homologous domains (I-IV), each containing six transmembrane (TM) segments, linked by intracellular loops and with intracellular N and C termini. There are 10 ␣1 subunits divided into three subfamilies, Ca V 1-3 (Ertel et al., 2000) .
Expression of two-domain isoforms of voltage-gated cation channels including Ca V 1.1, Ca V 1.2, and the Na ϩ channel SCN8A has been found to occur in a number of tissues, in some cases in a developmentally regulated manner (Plummer et al., 1997; Wielowieyski et al., 2001; Okagaki et al., 2001; Ahern et al., 2001; Arikkath et al., 2002) . Furthermore, mutations that result in truncations of calcium channel ␣1 subunits can contribute to a number of pathological states. For example, in episodic ataxia type-2 (EA2), mutations in Ca V 2.1 predict truncated forms of this channel (Ophoff et al., 1996; Denier et al., 1999) .
In our initial study on truncated Ca V ␣1 subunits, we showed that truncated constructs containing the first one or two domains of Ca V 2.2 suppressed Ca V 2.2 currents and reduced full-length Ca V 2.2 protein (Raghib et al., 2001) . Here, we have deduced a potential mechanism that also relates to a two-domain truncated Ca V 2.1 construct predicted by an EA2 mutation and have extended the finding to native calcium channels in neuronal cell lines. Our results suggest that suppression requires interaction between a truncated construct and a related full-length channel, which activates a component of the unfolded protein response (UPR) to suppress translation.
The UPR is initiated when the endoplasmic reticulum (ER) lumen is unable to cope with the load of newly synthesized proteins requiring folding (for review, see Harding et al., 2002 ). An early consequence is translation inhibition mediated by an ERresident RNA-dependent protein kinase (PERK). This is a trans-ER membrane protein with a cytoplasmic kinase domain and an ER lumenal domain that is activated by unfolded proteins in the ER (Harding et al., 1999) . PERK phosphorylates the ribosomal translation initiation factor eIF2␣ and in this way suppresses translation. In addition, there are other pathways activated by the UPR (Mori, 2000; Liu and Kaufman, 2003) . Furthermore, it has been found recently that the various pathways may also be activated separately, transiently, and with differential timing (for review, see Rutkowski and Kaufman, 2004) .
The activation of PERK is designed to protect cells during short-term stress (Mori, 2000; Harding et al., 2002) . However, if ER stress is prolonged, it will lead to cell death. With respect to its involvement in neuropathology, the UPR has been implicated in cellular models of Parkinson's disease (Ryu et al., 2002) and in neurodegeneration of the nigrostriatal tract in a familial form of Parkinson's disease involving mutations in the proteasomal pathway (Imai et al., 2001) . Our results suggest that it may also play a role in the pathophysiology of EA2.
Materials and Methods
Materials. The following cDNAs were used: Ca V 2.2 [D14157 without 3Ј untranslated region (UTR)], Ca V 2.1 [M64373 with E1686R mutation (Brodbeck et al., 2002) ], Ca V 2.3 (RbEII, L15453), Ca V 3.1 (AF027984), Ca V 1.2 (M67515), ␣2␦-1 (M86621), ␣2␦-2 (Barclay et al., 2001) , ␤1b (Tomlinson et al., 1993) , ␤4 (M80545), Kir2.1-AAA (Tinker et al., 1996) , and green fluorescent protein (GFP) mut3b (Cormack et al., 1996) in pMT2. PERK, PERK K618A, and PERK ⌬C terminus constructs were used in pcDNA1 (Harding et al., 1999) . K V 3.1b (M68880) was in pRC-CMV and Ca V 3.2 (AF051946) in pRK5.
Truncated and chimeric Ca v constructs. Constructs were made by standard techniques and verified by automated sequencing. The Ca V 2.2-Dom I, Ca V 2.2-Dom I-II, and GFP-Ca V 2.2-Dom I-II constructs have been described previously (Raghib et al., 2001 ). Other constructs used were Ca V 2.2-Dom I H6 [residues 1-483 plus a C-terminal His(6) tag], Ca V 3.1 containing a C-terminal Myc and His(10) tag, Ca V 2.1-P1217fs [residues 1-1216 with 27 additional amino acids attributable to the frame shift (fs)], Ca V 3.1-Dom I [residues 1-743, plus a C-terminal His(6) tag], Ca V 3.1-Dom I-II (residues 1-1253), and Ca V 3.2-Dom I (residues 1-791). The tags were used for Western blotting to confirm expression.
Cell culture and heterologous expression. COS-7 cells were cultured as described previously (Campbell et al., 1995) . The tsA-201 cells were cultured in a medium consisting of MEM, 10% FBS, and 1% nonessential amino acids. NG108-15 cells were cultured as described (Robbins et al., 1993) . PC12 cells were grown in DMEM, 7.5% FBS, and 7.5% horse serum. Cells were transfected using either Geneporter (Qbiogene, Harefield, UK) or Fugene (Roche Diagnostics, Mannheim, Germany), with equivalent results. The cDNAs (all at 1 g⅐l Ϫ1 ) for Ca V ␣1 subunits, truncated domain constructs, ␣2␦-1 or ␣2␦-2, ␤1b, and GFP when used as a reporter of transfected cells were mixed in a ratio of 3:1.5:2:1: 0.2, unless stated otherwise. When particular subunits were not used, the volume was made up with water, or blank vector, or the volume of transfection reagent was reduced, with equivalent results. PC12 cells were transfected using 4 l of cDNAs for GFP or GFP-Ca V 2.2-Dom I-II and Fugene. Differentiation was with serum-free medium containing NGF (100 ng/ml murine 7s NGF; Invitrogen, Carlsbad, CA), replenished every 48 hr. Cells were used for recording after 5-7 d of differentiation.
Xenopus oocytes were prepared, injected, and used for electrophysiology as described previously (Canti et al., 1999) , with the following exceptions. Plasmid cDNAs for the different calcium channel subunits ␣1, ␣2␦-2, and ␤1b and truncated domains and other constructs were mixed in equivalent weight ratios at 1 g⅐l Ϫ1 , unless stated otherwise, and 9 nl was injected intranuclearly. The corresponding mRNAs were made by mMessage mMachine (Ambion, Austin, TX), diluted to 0.5 g⅐l Ϫ1 , mixed in a ratio 3:1:1:3, and 60 nl was injected intracytoplasmically. For quantitative reverse transcription-PCR (QPCR), plasmid cDNAs for Ca v 2.2, ␤1b, ␣2␦-2, Kir2.1-AAA plus Ca v 2.2-Dom I, or blank vector were injected intranuclearly into oocytes in the ratio 6:2:2:1:3, unless stated otherwise. After ϳ48 hr, individual oocytes were harvested and RNA was isolated using RNeasy columns (Qiagen, Hilden, Germany), including an on-column DNase step.
Identification of a PERK gene product in Xenopus oocytes. Primers were designed by aligning Xenopus expressed sequence tag (EST) sequences (BU914407, BF427225, BI445972, BU912964, and CA791610) with mouse PERK (AF076681). The primers 5Ј-AGTCTCTGCTGGAGTCTTCA and 5Ј-TGACACTGTGTCTCAGACTCTT generated a 1145 bp product. The novel sequence represented by part of this PCR product was submitted to GenBank (accession number AY512645). Translation of this PCR product, combined with the EST sequences BU911407 and BI445972, gave a fragment of 425 aa. A second PCR product generated using the primers 5Ј-GTCGCGGTACCTCACAGATT and 5Ј-CACAGCTGCATCTGGATGTA gave a 921 bp product. The sequence of this confirms the EST BU912964.
Measurement of mRNA levels by QPCR. Reverse transcription was performed using random hexamer primers and Moloney murine leukemia virus reverse transcriptase (Promega, Madison, WI) at 37°C for 2 hr. QPCR was performed with an iCycler (Bio-Rad, Hercules, CA) using the iQ SYBR supermix. For each set of primers and for every experiment, a standard curve was generated using a serial dilution of reverse-transcribed RNA combined from several oocytes. The following primers were used: Ca v 2.2, 5Ј-CTCTGCGCTTACTGAGAATC and 5Ј-AACAGGAAGAG-CAGGAAGAG; Kir2.1-AAA, 5Ј-TGGGTGAGAAGGGACAGAGGTA and 5Ј-AGGAGAGCACGAAGGCAAGAC; 18S, 5Ј-TGACTCAACACGGG-AAACCT and 5Ј-AATCGCTCCACCAACTAAGAAC; PERK, 5Ј-GGACC-AAGAAGAAGATGAAGAA and 5Ј-CTGTGTGCTGAATGGGTATAA. Data were analyzed using REST software (Pfaffl et al., 2002) and normalized for expression of 18S ribosomal RNA.
Western blotting and calcium channel subunit quantification. COS-7 cells were processed for SDS-PAGE as described (Raghib et al., 2001) . Western blotting of individual oocytes was performed as described . Individual oocytes were lysed, solubilized, centrifuged (10,000 ϫ g, 5 min), and the supernatants were assayed for total protein content as described ). Samples (50 or 30 g of cell lysate protein/lane for COS-7 cells and oocytes, respectively) were separated using Novex 4 -12% Tris-glycine or 4 -12% Bis-Tris NuPAGE gels (Invitrogen) and transferred electrophoretically to polyvinylidene fluoride membranes. The membranes were blocked with 3% BSA/0.02% Tween 20 and then incubated overnight at room temperature with the relevant primary antibody: 1:1000 dilution of anti-Ca v 2.2 (Raghib et al., 2001) , protein A IgG cut from anti-␤1b serum used at 10 g/ml, anti-␣2␦-2 Ab102-117 used at 1 g/ml (Brodbeck et al., 2002) , 1:1000 dilution of His-probe Ab (Santa Cruz Biotechnology, Santa Cruz, CA), or 1:1000 dilution of c-myc 9E10 Ab (Santa Cruz Biotechnology). Detection was performed either with a 1:1000 dilution of goat anti-rabbit (or anti-mouse) IgG-HRP conjugate (Bio-Rad Laboratories, Richmond, CA) and ECLplus (Amersham Biosciences (Amersham Biosciences), Little Chalfont, UK), or with a 1:1000 dilution of goat anti-rabbit IgG-Cy5 conjugate (Amersham Biosciences), all in conjunction with a Typhoon 9410 Variable Mode Imager (Amersham Biosciences), set in chemiluminescence or fluorescence mode, respectively. Protein bands were quantified using Imagequant version 5.2.
Electrophysiology. Whole-cell patch-clamp recording was performed and analyzed as described (Meir et al., 2000) , with 1-20 mM Ba 2ϩ as charge carrier (as stated) and a holding potential of Ϫ100 mV. Currents were measured 10 msec after the onset of the test pulse, and the average over a 2 msec period was calculated and used for analysis. Xenopus oocyte recordings were performed as described ). The holding currents at Ϫ100 mV were stable and usually in the range Ϫ50 to Ϫ100 nA. The Ba 2ϩ concentration was 5 mM, unless stated otherwise. Data are expressed as means Ϯ SEM, and I-V plots were fit with a modified Boltzmann equation as described . K ϩ currents were recorded as described . When used, thapsigargin (Sigma, St. Louis, MO) was dissolved in DMSO at 1 mM. Xenopus oocytes were incubated with thapsigargin (1 M) or the equivalent amount of DMSO as control, from 12 hr after cDNA injection to the time of Ca V 2.2 recording (ϳ48 hr).
Results
The first set of experiments was performed in Xenopus oocytes because the amount and proportions of different cDNAs received by each oocyte can be accurately controlled, and biochemical studies can be performed on the individual oocytes from which recordings were made, without the factor of transfection efficiency that may confound the comparison of electrophysiological and biochemical data when using transient transfection of mammalian cells. We first confirmed that the suppression of Ca V 2.2 currents by truncated Ca V 2.2 constructs also occurred in this system. The Ca V 2.2-Dom I produced almost 90% suppression of Ca V 2.2 currents in Xenopus oocytes ( Fig. 1 A, C; Table 1), with no significant effect on steady-state inactivation (data not shown). Two controls were performed. First, coexpression of Ca V 2.2 channels with a control nonfunctional membrane protein, a mutant Kir2.1 construct that has a mutated pore signature sequence (GYG3 AAA) rendering it nonconducting (Tinker et al., 1996) , produced no inhibition of Ca V 2.2 barium current (I Ba ) (Table 1) . Second, coexpression of Ca V 2.2-Dom I with another voltagegated channel, K V 3.1b, produced no significant inhibition of this K ϩ current (data not shown).
Does suppression by truncated Ca V ␣1 domains involve activation of a component of the UPR?
We showed in our previous report (Raghib et al., 2001 ) that Ca V 2.2 protein levels were reduced when the channel was coexpressed with Ca V 2.2-Dom I-II. One process that might mediate this reduction is the UPR. This response is initiated when the ER lumen is unable to cope with the load of newly synthesized proteins requiring folding ). An early consequence is translation inhibition mediated by the ER-resident PERK (Harding et al., 2000) . To examine whether this pathway is involved in the suppression of expression of Ca V 2 channels by truncated constructs, we determined the effect of two dominantnegative PERK constructs on Ca V 2.2 expression and its suppression by Ca V 2.2-Dom I. These were PERK K618A with a point mutation in its catalytic site and PERK ⌬C lacking the C-terminal kinase domain, both of which prevent activation of endogenous PERK (Harding et al., 1999) . When Ca V 2.2-Dom I was coexpressed with Ca V 2.2, together with the dominant-negative PERKs, a significant reversal of suppression was observed. With PERK K618A, there was only a 55.2% suppression of Ca V 2.2 currents ( Fig. 1 A, C) . PERK ⌬C also significantly reduced the suppressive effect of Ca V 2.2-Dom I (Fig.  1 A) . It has previously been shown that overexpression of wildtype PERK is able to produce some inhibition of translation, presumably by overwhelming the mechanisms that suppress dimerization and activation of endogenous PERK (Harding et al., 1999) . In agreement with this, when wild-type PERK was coexpressed with Ca V 2.2 in the absence of any truncated constructs, it reduced Ca V 2.2 I Ba by 71.1% ( Fig. 1 B, C) , indicating that overexpression of PERK itself is able to suppress translation of calcium channels. The PERK K618A mutant, which is unable to suppress translation (Harding et al., 1999) , was ineffective in this regard ( Fig. 1 B, C) . These results indicate that activation of PERK plays a role in the suppression of Ca V 2.2 currents by truncated domains. In agreement with this finding, thapsigargin, which is a global initiator of UPR and an activator of PERK (Harding et al., 1999) , had a similar effect. Continuous incubation of Xenopus oocytes with thapsigargin (1 M) from 12 hr after cDNA injection inhibited Ca V 2.2 current expression by ϳ90% (Fig. 1C) . These oocytes were visually healthy and had normal holding currents at Ϫ100 mV. Does activation of PERK play a role in dominant-negative suppression of Ca V 2.1 by the truncated protein predicted by an EA2 mutation? Truncated Ca V 2.1 channels are potentially expressed as a result of a number of EA2 mutations. We examined the effect of an EA2 mutation at the beginning of domain III, caused by a single base pair deletion at C 4073 (Ophoff et al., 1996) that predicts expression of a two-domain isoform. We first determined whether it would produce a dominant-negative effect in the same way as truncated Ca V 2.2 constructs. When the EA2 mutant construct (Ca V 2.1-P1217fs) was expressed from cDNA in Xenopus oocytes, together with ␣2␦-2 and ␤4 to mimic Purkinje cell calcium channels (Barclay et al., 2001) , it inhibited Ca V 2.1 currents by 93% (Fig. 2 A; Table 1 ). These data were confirmed using COS-7 cells, in which the reduction was 94% (Table 1) .
We next examined the effect of coexpression of both dominant-negative PERK constructs on Ca V 2.1 expression and Figure 1 . The effect of PERK and dominant-negative PERK constructs on suppression of Ca V 2.2 I Ba by Ca V 2.2-Dom I. A, Ca V 2.2/␣2␦-2/␤1b I Ba recorded in Xenopus oocytes, either in the absence (f; n ϭ 29) or presence of Ca V 2.2-Dom I (E; n ϭ 19), Ca V 2.2-Dom I plus PERK K618A ( ; n ϭ 24), or Ca V 2.2-Dom I plus PERK ⌬C (F; n ϭ 18). The mean I-V plots gave maximum conductance (G max ) values of 38.6, 6.1, 19.4, and 15.4 S, respectively. B, Ca V 2.2/␣2␦-2/␤1b I Ba recorded in the same experiments either in the absence (f; n ϭ 20) or presence of PERK (E; n ϭ 15) or PERK K618A (‚; n ϭ 26). The mean I-V plots gave G max values of 24.7, 9.4, and 27.0 S, respectively. C, Left, Histogram of all mean data obtained at 0 mV for control Ca V 2.2/␤1b/ ␣2␦-2 I Ba (f; n ϭ 35) in the presence of PERK (( ; n ϭ 24), PERK K618A (( ; n ϭ 26), Ca V 2.2-Dom I (Ⅺ; n ϭ 26) or Ca V 2.2-Dom I plus PERK K618A (o; n ϭ 27). Right, Effect of incubation of oocytes with thapsigargin (TG; 1 M; n ϭ 3; Ⅺ) compared with control (incubated with the same concentration of DMSO; f; n ϭ 10). Only 3 of 10 thapsigargin-treated oocytes showed any current compared with 10 of 11 control oocytes that expressed Ca V 2.2 currents in the same experiment. The mean peak I Ba at 0 mV is expressed relative to control. Statistical significance compared with control or Ca V 2.2-Dom I where indicated: **p Ͻ 0.001. D, Examples of I Ba : left, Ca V 2.2/␤1b/␣2␦-2; center, plus Ca V 2.2-Dom I; right, plus Ca V 2.2-Dom I and PERK K618A. The calibration bar refers to all panels. I Ba is shown in 5 mV steps between Ϫ40 and 0 mV. its suppression by Ca V 2.1-P1217fs. There was a significant reduction in the suppression of peak I Ba , for both PERK K618A and PERK ⌬C, to 62.6 and 46.8% suppression, respectively ( Fig.  2 B, C) . These results indicate that PERK activation also plays a part in the suppression of Ca V 2.1 currents by Ca V 2.1-P1217fs.
Confirmation of the presence of endogenous PERK in oocytes
For the kinase-dead PERK ⌬C and PERK-K618A constructs to behave in a dominant-negative manner, they must interact with native PERK to form nonfunctional dimers, and it was therefore imperative to demonstrate the expression of PERK in Xenopus oocytes. The PERK gene is highly conserved, and we identified, by RT-PCR, a transcript with strong sequence homology to murine PERK in Xenopus oocytes. A 425 aa fragment encompassing the ER lumenal domain and part of the TM domain showed 81% identity and 90% similarity with mouse PERK used in the present study. Published EST sequences BU912964 and CA791610 were also expressed in oocytes and showed a similar level of homology within the two lobes of the kinase domain (93% identity, 98% similarity with the first lobe and 83% identity, 91% similarity with the second lobe of the kinase domain in mouse PERK). Endogenous PERK mRNA, measured by QPCR, was not altered by coexpression of Ca V 2.2 and Ca V 2.2-Dom I (data not shown), in agreement with previous evidence that its activity is upregulated by phosphorylation (Harding et al., 1999) rather than increased expression.
Does the suppression of Ca V expression by truncated constructs involve interaction between full-length and truncated channels?
The activation of PERK might be triggered either by the truncated domain alone or by its interaction with the full-length Ca V 2 channel. To examine this issue, we studied the specificity of inhibition between different calcium channel family members. Because the TM segments, as well as the N termini and proximal C termini of all the Ca V 2 channels, are very similar, we examined first whether there would be cross-suppression between different pairs of full-length and truncated channels within the Ca V 2 calcium channel family. We found that Ca V 2.2-Dom I-II markedly inhibited both Ca V 2.1 and Ca V 2.3 currents by 40 and 48%, respectively (Table 1) , and reciprocally Ca V 2.1-P1217fs inhibited Ca V 2.2 currents by 50% (Table 1) . From these results, although we have not examined every combination, it appears that there is a generalized cross-suppression by truncated domains within the Ca V 2 family.
Cross-suppression does not occur between the Ca V 2 and Ca V 3 families We extended our investigation of cross-suppression to the more distantly related Ca V 3 calcium channels. There is currently no evidence that truncated Ca V 3 channels are expressed physiologically or pathologically, but this remains a possibility. First, we examined whether truncated constructs of the Ca V 3 family could inhibit the expression of the cognate full-length Ca V 3 channels. Both Ca V 3.1-Dom I and Ca V 3.1-Dom I-II markedly inhibited Ca V 3.1 currents by 63 and 50%, respectively ( Fig. 3A,B ; Table 1 ). Furthermore, Ca V 3.2-Dom I inhibited Ca V 3.2 currents by 89% (Table 1) . The inhibition of Ca V 3.1 by Ca V 3.1-Dom I was also associated with a suppression of protein expression by 86% (Fig. 3C) .
To study whether the cross-suppression extended between the Ca V 2 and Ca V 3 subfamilies, we examined whether any truncated domains of Ca V 2.1 or Ca V 2.2 would inhibit Ca V 3.1 currents. No significant inhibition was observed by Ca V 2.2-Dom I, Ca V 2.2-Dom I-II, or Ca V 2.1-P1217fs (Fig. 4 A; Table 1 ), indicating that there is a specificity in the process of suppression. In agreement with this, there was little effect of Ca V 2.2-Dom I-II on Ca V 3.1 protein levels (Fig. 4 B) . The specificity of cross-suppression is further borne out by the lack of effect of Ca V 3.1-Dom I on Ca V 2.2 currents ( Fig. 4C; Table 1 ). These results strongly suggest that the suppression of Ca V currents by truncated constructs is triggered primarily by an interaction of the truncated channel in the ER with a related channel.
What is effect of coexpression of a truncated domain on Ca V 2.2 protein and mRNA levels? Our working hypothesis for the sequence of events leading to suppression of Ca V channel expression is that the truncated domains, being much smaller than the full-length Ca V , would be synthesized in the ER more rapidly than the full-length channels. Both Ca V 2.2-Dom I and Ca V 2.2-Dom I-II are detectable by Western blotting 8 hr after transfection of COS-7 cells, whereas fulllength Ca V 2.2 only begins to be expressed between 20 and 32 hr after transfection (data not shown). The truncated channels would then be able to interact with the nascent full-length channels, possibly during the process of their synthesis, forming an aggregate that could not be trafficked out of the ER. We hypoth- esize that this would then activate PERK and prevent additional translation. We therefore examined the effect of the Ca V 2.2-Dom I on the level of full-length Ca V 2.2 protein under the different conditions. In parallel with the suppressive effect of Ca V 2.2-Dom I observed electrophysiologically, Ca V 2.2 protein was reduced by ϳ80%, both in COS-7 cells (Fig. 5A ) and in Xenopus oocytes (Fig.  5B ). This is in agreement with the main effect of the activation of PERK being inhibition of translation (Harding et al., 1999) . In oocytes showing elevated currents on coexpression of PERK-K618A, from which recordings were made for Figure 1C , there was a smaller reduction in Ca V 2.2 protein (Fig. 5B) . Expression of the ␣2␦-2 subunit protein, which is also synthesized on the ER and is highly glycosylated, was also markedly suppressed by 73% when coexpressed with Ca V 2.2/␤1b and Ca V 2.2-Dom I (n ϭ 10) (Fig. 5C) , whereas there was little suppression of expression of the cytoplasmic ␤1b subunit (n ϭ 10) (Fig. 5C ).
In agreement with the marked effect of thapsigargin (1 M) on the level of Ca V 2.2 currents expressed in Xenopus oocytes, it also produced a striking reduction in Ca V 2.2, ␣2␦-2 and ␤1b protein levels by 93, 67, and 90%, respectively (n ϭ 3) (Fig. 5D ). Overexpression of PERK itself, together with Ca V 2.2/␤1b/␣2␦-2, also reduced calcium channel subunit levels in Xenopus oocytes, in agreement with its effect on Ca V 2.2 currents. The ␣2␦-2 and ␤1b protein levels were 70.5 Ϯ 5.8% and 65.6 Ϯ 6.7% of control (n ϭ 7).
We also examined whether the proteasomal pathway was involved in the loss of Ca V 2.2 protein induced by coexpression with Ca V 2.2-Dom I. However, we observed no effect of incubation of COS-7 cells with lactacystin (30 M; replaced twice during the 48 hr period between transfection and harvesting) on Ca V 2.2 protein levels or on the appearance of high molecular weight Ca V 2.2-immunoreactive species that might represent poly-ubiquitinated Ca V 2.2 in the presence of Ca V 2.2-Dom I (data not shown).
If PERK is activated, resulting in phosphorylation of its substrate eIF2␣, translation initiation will be prevented and there will be ribosome disassembly. The binding of nonphosphorylated eIF2␣ is involved in the process of association of the two ribosomal subunits (Pestova et al., 2001 ). In general, mRNA is stabilized by association with intact ribosomes (Mazumder et al., 2003) . To examine whether there might therefore be a secondary effect on Ca V 2.2 mRNA levels of interaction between the fulllength and the truncated Ca V 2.2 proteins, we coexpressed Ca V 2.2-Dom I with full-length Ca V 2.2 and accessory subunits and examined mRNA levels in individual Xenopus oocytes injected with cDNA. Because the stability of Ca V 2.2 mRNA has also been shown to be governed by sequences in the 3Ј UTR (Schorge et al., 1999) , in the present study the 3Ј UTR was removed from the Ca V 2.2 construct used for the oocyte expression experiments. In all these oocytes, I Ba was measured to ensure expression. From QPCR measurements, Ca V 2.2-Dom I reduced full-length Ca V 2.2 mRNA by 63.4% (Fig. 6 A) . This suppression is not a nonspecific effect of the inclusion of additional cDNA for a TM protein because inclusion of Kir2.1-AAA, in place of Ca V 2.2-Dom I cDNA, did not reduce the Ca V 2.2 mRNA level (Fig. 6B) . However, when Kir2.1-AAA cDNA was included together with Ca V 2.2-Dom I and Ca V 2.2, the Kir2.1-AAA mRNA was also reduced by 63.7% (Fig. 6C) . This reduction requires the presence of both the full-length and the truncated calcium channel because Kir2.1-AAA mRNA was not reduced by Ca V 2.2-Dom I when K V 3.1 cDNA was included in place of Ca V 2.2 (Fig. 6D ), in agreement with the lack of effect of Ca V 2.2-Dom I on K V 3.1 currents. The reduction of Kir2.1-AAA mRNA, when it is coexpressed with Ca V 2.2 and Ca V 2.2-Dom I, indicates that there is a global effect at least on mRNAs translated on ER-associated ribosomes. In general, this result indicates that a component of the suppression of Ca V 2.2 currents by Ca V 2.2-Dom I is also likely to involve degradation of mRNA.
In agreement with these results, Ca V 2.2-Dom I was less effective in suppressing Ca V 2.2 currents when all constructs were expressed from synthetically capped mRNA injection into Xenopus oocytes. Coexpression of Ca V 2.2-Dom I mRNA with Ca V 2.2 produced a 48.6 Ϯ 5.4% inhibition (n ϭ 20; p Ͻ 0.01 compared with Ca V 2.2 alone) of the maximum I Ba . Injection of twice the amount of Ca V 2.2-Dom I mRNA only produced a small additional suppression of Ca V 2.2 currents, to 58.4% inhibition (n ϭ 22; p Ͻ 0.01 compared with Ca V 2.2). Do truncated Ca V ␣1 constructs inhibit endogenous calcium channels? For the mechanism described here to be relevant to developmental or disease states and also to have potential as a tool to knock down calcium channel function, it is necessary to show that the truncated channel constructs can inhibit native calcium currents. For this, we used two cell lines with neuronal phenotypes, PC12 and NG108 -15. The PC12 cell line used in this study had a very low density of calcium channels when undifferentiated (Fig. 7A ) but expressed high voltage activated (HVA) currents when differentiated with NGF. After 5 d of differentiation, peak I Ba was increased from Ϫ5.4 to Ϫ19.9 pA/pF (Fig. 7A) , and this was reduced by 61.4% by 1 M -conotoxin GVIA. When cells were transfected with GFP-Ca V 2.2-Dom I-II and then differentiated, the peak HVA current amplitude was reduced by 84.9 Ϯ 8.2% compared with differentiated controls transfected with GFP and was no greater than that in undifferentiated cells (Fig. 7A) . When PC12 cells were transfected with PERK, together with GFP and then differentiated, the peak currents were also reduced by 39.9% (n ϭ 11) compared with cells transfected with cDNA for a control protein, Kir1.2-AAA, together with GFP.
NG108 -15 cells contain endogenous T-type channels when undifferentiated and have been shown to express Ca V 3.2 mRNA (Chemin et al., 2002) . These cells were therefore transfected with Ca V 3.2-Dom I or Kir1.2-AAA as a control, together with GFP. Three days after transfection, the peak native T-type currents were reduced in the Ca V 3.2-Dom I-transfected cells by 49.2 Ϯ 10.6% compared with control (Fig. 7B) . There was no difference in any of the biophysical properties examined (voltage dependence of activation, time constant of inactivation) (Fig. 7B , traces) apart from current density.
Discussion
Translational suppression of Ca V 2 channel expression by truncated domains involves the UPR Accumulation of misfolded proteins within the ER triggers the UPR pathway (Mori, 2000; Liu and Kaufman, 2003) . This pathway has been elucidated previously with global initiators of UPR, including thapsigargin, rather than by using specific unfolded proteins. In our study, thapsigargin suppressed Ca V 2.2 currents and Ca V 2.2 protein expression by a similar extent to Ca V 2.2-Dom I. One of the important initiators of the UPR is the ER membrane-resident kinase PERK (Harding et al., 1999) .
We used two mutant PERK constructs, PERK K618A and PERK ⌬C (Harding et al., 1999) , both of which lack kinase activity. Their dominant-negative behavior stems from the fact that they form nonfunctional dimers with endogenous PERK. The mutant PERKs markedly reduced the inhibition of Ca V 2.1 expression by the EA2 mutant construct Ca V 2.1-P1217fs and the inhibition of Ca V 2.2 expression by Ca V 2.2-Dom I, while having no effect in the absence of the truncated channel. This implicates endogenous PERK in the process of suppression. The reversal of this suppression by the dominant-negative PERKs was rarely complete. One obvious reason is that, although the dominantnegative PERKs reduced the translational suppression, counter-productive interaction between full-length and truncated channels would still occur in the ER.
Although global initiators of ER stress such as thapsigargin cause a widespread inhibition of protein synthesis, it has been suggested that more localized activation of PERK, which is itself tethered in the ER, may restrict inhibition of translation to particular ER-bound ribosomes (Ron, 2002) . In agreement with this hypothesis, we found that the level of Ca V ␤ protein was not significantly affected by the coexpression of Ca V 2.2 and Ca V 2.2-Dom I, whereas there was a consistent reduction in ␣2␦-2 expression. Being a highly glycosylated type I membrane protein, ␣2␦-2 is profoundly dependent on the ER for synthesis and maturation.
The ER membrane-resident kinase PERK acts at the level of translation
The primary effect of activation of PERK is suppression of capdependent translation initiation by phosphorylation of eIF2␣ (Harding et al., 1999) , which prevents the formation of the 80S ribosome complex (Pestova et al., 2001) , and our results indicate that this mechanism is involved in the suppression of Ca V 2.2 expression by Ca V 2.2-Dom I. However, in our study, there was also a consistent reduction in the Ca V 2.2 mRNA level in the presence of Ca V 2.2-Dom I, which we hypothesized as being secondary to the activation of PERK for the following reasons. The effect of Ca V 2.2-Dom I on Ca V 2.2 currents and protein was much greater (80 -90% decrease) than the effect on Ca V 2.2 mRNA (ϳ60% decrease), suggesting that the reduction in mRNA is not the main cause of the loss of protein, although it would inevitably contribute to it. Phosphorylation of eIF2␣ by PERK, which leads to ribosome disassembly and prevention of translation initiation, results directly in a reduction in translation, but secondarily it may cause an increased rate of mRNA degradation. It is known that when mRNA is associated with intact polysomes it is stabilized (e.g., by circularization with both the cap and the polyA tail being bound by the ribosome) (Sachs and Varani, 2000; Mazumder et al., 2003) . However, it is also possible that other unknown parallel mechanisms are activated by the UPR to reduce transcription or mRNA stability.
Interaction between truncated and full-length channel is required for suppression of calcium channel expression We observed cross-suppression between the different subclasses of Ca V 2 channels (Ca V 2.1, Ca V 2.2, and Ca V 2.3), in which conservation within TM segments is very high. However, there was no significant cross-suppression between full-length Ca V 3.1 and truncated constructs of Ca V 2.2, and vice versa. This suggests that interaction occurs between the truncated domain and segments of a cognate full-length channel with which it shows an affinity.
Inappropriate intermolecular interactions, substituting for the appropriate intramolecular interactions that lead to the mature folded protein (so-called domain swapping) are generally the basis for pathological protein aggregation (for review, see Horwich, 2002) . It is probable that truncated calcium channels interfere with one or more essential interactions between the domains within a single full-length channel required for it to fold into its mature form. We are currently investigating the specific domains involved in this interaction. The incorrectly assembled channels, aggregated with the truncated domain, are likely to remain in the ER and will then be in a position to trigger translational suppression by activation of PERK. This does not preclude the finding that some truncated channels may reach the plasma membrane, as was shown to occur previously (Ahern et al., 2001; Raghib et al., 2001 ).
Whereas we did not obtain evidence in the present study for the additional involvement of the proteasomal pathway, additional work is underway to examine ubiquitination of Ca V 2.2.
Lack of involvement of sequestration of the Ca V ␤ subunit Our evidence does not support the view that the major mechanism of suppression involves sequestration by truncated domains of Ca V ␤ subunits. As described in our initial study, overexpression of the Ca V ␣1 I-II linker to sequester ␤ subunits did not mimic suppression of Ca V 2.2 currents or protein (Raghib et al., 2001) , and Ca V 3.1 current suppression occurred in the absence of Ca V ␤ subunits. We also found that there was no depolarizing shift of steady-state inactivation associated with suppression, which would have been indicative of depletion of Ca V ␤ subunits.
Suppression of native calcium currents by truncated channel constructs
We have shown that endogenous T-type and HVA calcium currents are substantially inhibited by relevant truncated constructs in neuronal cell lines. The complete suppression by Ca V 2.2-Dom I-II of de novo synthesized HVA channels in PC12 cells is in accordance with the preferential enhancement of N-type channel expression on differentiation with NGF (Usowicz et al., 1990) . The smaller reduction of preexisting T-type currents in NG108-15 cells by Ca V 3.2-Dom I is understandable because turnover of the existing T-type channels must also occur.
Relationship to EA2 and other calcium channelopathies
We have demonstrated the ability of a construct mimicking an EA2 mutation (Ophoff et al., 1996) , which predicts the expression of the first two domains of Ca V 2.1, to markedly suppress the expression of Ca V 2.1 currents. This is in agreement with the work 2-Dom I (n ϭ 8; 80 Ϯ 7.5% reduction by Ca V 2.2-Dom I). Accessory ␣2␦-2 and ␤1b subunits were also present. B, Ca V 2.2 protein levels determined by immunoblotting in individual Ca V 2.2/␣2␦-2/␤1b-injected oocytes in the absence (lane 1) or presence (lane 2) of Ca V 2.2-Dom I (n ϭ 3; 80.7 Ϯ 0.4% reduction) or in the additional presence of PERK K618A (lane 3). Lane 4, Non-injected control oocyte. C, Protein levels for ␣2␦-2 (top) and ␤1b (bottom) determined by immunoblotting of individual oocytes injected with Ca V 2.2/␣2␦-2/␤1b in the absence (lane 1) or presence (lane 2) of Ca V 2.2-Dom I (n ϭ 10; 72.9 Ϯ 1.8% reduction of ␣2␦-2 and 9.2 Ϯ 3.3% reduction of ␤1b). Lane 3, Non-injected control oocyte. D, Effect of thapsigargin on Ca V 2.2, ␣2␦-2 and ␤1b protein levels. Left, Control oocyte (n ϭ 10); right, oocyte incubated with thapsigargin (1 M; n ϭ 3). The mean percentage of reductions were 93.5 Ϯ 2.8, 67.4 Ϯ 16.1, and 89.9 Ϯ 4.5%, respectively.
of others on an EA2 construct (R1820Stop) truncated near the end of domain IV (Jouvenceau et al., 2001) . In contrast, in a study of another EA2 construct (R1279Stop), in which the construct was expressed from human cRNA, no dominant-negative suppression was reported (Wappl et al., 2002) . The reason for this discrepancy is unclear but may involve species or methodological differences.
Our finding that PERK activation is involved in the suppression of Ca V 2.1 expression by Ca V 2.1-P1217fs suggests that the UPR pathway may be involved in the cerebellar dysfunction seen in EA2. The symptoms of EA2 are exacerbated by physiological stresses including fever (Subramony et al., 2003) , and it is tempting to speculate that this might synergize with the effect of truncated channels in terms of cellular stress. This would provide a gain-of-function mechanism as to why this disease is dominant and episodic, rather than being attributed solely to haploinsufficiency. However, it is likely that nonsense-mediated mRNA decay (Dreyfuss et al., 2002) limits the amount of truncated Ca V 2.1 proteins expressed to an extent depending on the specific mutation. This would mitigate the neurotoxic effects of the truncated channel and provide a basis for the variable phenotype of disease. Our findings may also help explain the discrepancy between the lack of any reduction in P/Q-type currents in the cerebellar granule cells of heterozygotes of a Ca V 2.1 knock-out mouse disrupted early in domain I (Jun et al., 1999) , whereas in a mouse in which the disruption of Ca V 2.1 was within domain II, allowing the possibility of truncated protein production, the calcium currents in heterozygotes were ϳ50% of normal (Fletcher et al., 2001) .
It is possible that UPR pathways are also involved in other human and mouse calcium channelopathies showing cerebellar degeneration. The lack of ␤4 in the lethargic mouse (Burgess et al., 1997) , might lead to accumulation of immature ␣1 subunits in the ER of Purkinje neurons, in which ␤4 is the predominant ␤ subunit, potentially leading to chronic ER stress. Similarly, the ducky mouse has a mutation resulting in a truncated product of ␣2␦-2 in Purkinje neurons (Brodbeck et al., 2002) .
Voltage-gated channels represent a class of difficult-to-fold membrane proteins because of their size, the presence of a pore, and charged residues in their TM segments. In the case of HVA calcium channels, this is compounded by the need to associate with auxiliary subunits to enable maturation and trafficking out of the ER. In one study, a domain responsible for the low expression of Ca V 2.1 was identified (Hans et al., 1999) . In the present study, Ca V 2.1 expression was more markedly inhibited by Ca V 2.1-P1217fs (Ͼ90%) than was Ca V 2.2 by its cognate twodomain construct (Raghib et al., 2001 ). Thus, Ca V 2.1 may be particularly prone to mutations and conditions affecting its folding and assembly. It will be of great interest to examine the generality of this hypothesis in the future.
